Roster of the Vaccines and Related Biological Products Advisory Committee
Applying for Membership on FDA Advisory Committees
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 0
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Hana M. El Sahly, M.D.***
Expertise: Vaccines, Infectious Diseases
Term: 06/10/2016 - 01/31/2026
Professor
Departments of Molecular Virology and
Microbiology and Medicine
Baylor College of Medicine
Houston, TX 77030
Expertise: Global Health, Genetics
Term: 02/01/2022 - 01/31/2026
Director
Division of Clinical and Healthcare Research Policy
Office of Science Policy, Office of the Director
National Institutes of Health
Bethesda, MD 20892
Expertise: Pediatrics
Term: 02/01/2022 - 01/31/2026
Professor of Pediatrics
Zucker School of Medicine at Hofstra/Northwell
Department of Pediatrics
Cohen Children’s Medical Center
New Hyde Park, NY 11042
Expertise: Pediatrics, Infectious Diseases
Term: 06/21/2019 - 01/31/2027
Dean of Chicago Medical School
Vice President for Medical Affairs
Rosalind Franklin University of Medicine & Science
North Chicago, IL 60064
Expertise: Pediatrics, Infectious Diseases
Term: 06/21/2019 - 01/31/2027
Clinical Professor
Pediatrics - Infectious Diseases
Stanford Medicine Children’s Health
Stanford, CA 94305
Expertise: Biostatistics
Term: 06/10/2016 - 01/31/2025
Professor
Vaccine and Infectious Disease Division
Public Health Sciences Division
Fred Hutchinson Cancer Center
Seattle, WA 98109
Expertise: Alternate Industry Representative
Term: 02/01/2024 - 01/31/2028
Chief Medical Officer and Senior Vice President
Clinical Development
Dynavax Technologies Corporation
Emeryville, CA 94608
Expertise: Industry Representative
Term: 02/01/2024 - 01/31/2028
Chief Medical Officer and Senior Vice President
Vaccines
Pfizer, Inc.
New York, NY 10001
Expertise: Pediatrics, Vaccines
Term: 02/01/2024 - 01/31/2028
Chief Medical Officer
Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, GA 30329
Expertise: Epidemiology
Term: 02/01/2022 - 01/31/2026
Thomas Francis Jr. Collegiate Professor Emeritus of
Public Health and Epidemiology
School of Public Health
University of Michigan
Ann Arbor, MI 48109
Expertise: Allergy & Immunology
Term: 07/05/2024-1/31/2028
Chief
Asthma, Allergy and Immunology Division
School of Medicine
University of Virginia
Charlottesville, VA 22903
Expertise: Infectious Diseases
Term: 02/01/2018 - 01/31/2025
Director
Vaccine Education Center
Professor of Pediatrics
Division of Infectious Diseases
Children’s Hospital of Philadelphia
Maurice R. Hilleman Professor of Vaccinology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA 19104
Expertise: Infectious Diseases
Term: 02/01/2020 - 01/31/2025
Professor
Vaccine and Infectious Disease Division
Medical Director of Infection Control
Fred Hutchinson Cancer Center
Seattle, WA 98109
Expertise: Pediatrics, Infectious Diseases
Term: 08/23/2022 - 01/31/2026
Professor
University of Iowa Distinguished Chair
Department of Microbiology and Immunology
Carver College of Medicine
University of Iowa
Iowa City, IA 52242
Expertise: Consumer Representative
Term: 02/01/2022 - 01/31/2025
Professor of Pediatrics
University of Missouri – Kansas City
School of Medicine
Director
Division of Allergy, Asthma, and Immunology
Children’s Mercy Hospitals and Clinics
Kansas City, MO 64108
Expertise: Infectious Diseases
Term: 02/01/2022 - 01/31/2026
Editor-in-Chief, New England Journal of Medicine
Adjunct Professor
Department of Immunology & Infectious Diseases
Harvard T.H. Chan School of Public Health
Associate Physician
Brigham and Women’s Hospital
Boston, MA 02115
Expertise: Pediatrics, Infectious Diseases
Term: 02/01/2018 - 01/31/2025
Professor of Pediatrics
Division of Infectious Disease
Marcus Professor of Hospital Epidemiology and
Infection Prevention
Emory University School of Medicine
Atlanta, GA 30322
** Industry Representative
+ Alternate Industry Representative
*** Chairperson
Sussan Paydar, Ph.D.
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CBERVRBPAC@fda.hhs.gov
Prabhakara Atreya, Ph.D.
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CBERVRBPAC@fda.hhs.gov
Kathleen Hayes, M.P.H.
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CBERVRBPAC@fda.hhs.gov
Joanne Lipkind, M.S.
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CBERVRBPAC@fda.hhs.gov
Lisa Johnson
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CBERVRBPAC@fda.hhs.gov